- Filed
- Apr 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 48.4M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $909M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $908M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $349M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $360M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.65B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.98B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.71B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.05B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.86B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.18B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.78B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.12B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 51M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $23M |
| Capex | Q1 2025 · Mar 31, 2024 | $18M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $91M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $143M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $78M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.78 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.80 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $48M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $18M |
| Net Income | Q1 2025 · Mar 31, 2024 | $91M |